Loading…

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of infiltrating inflammatory/immune cells in HCC and can amplify inflammatory response via binding to interleukin-17 receptor (IL-17R). T...

Full description

Saved in:
Bibliographic Details
Published in:Journal of experimental & clinical cancer research 2013-01, Vol.32 (1), p.3-3, Article 3
Main Authors: Liao, Rui, Sun, Jian, Wu, Han, Yi, Yong, Wang, Jia-Xing, He, Hong-Wei, Cai, Xiao-Yan, Zhou, Jian, Cheng, Yun-Feng, Fan, Jia, Qiu, Shuang-Jian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of infiltrating inflammatory/immune cells in HCC and can amplify inflammatory response via binding to interleukin-17 receptor (IL-17R). Thus, we investigated the expression and clinical significance of IL-17 and IL-17 receptor family cytokines in HCC. The expression and prognostic value of IL-17 and IL-17R (A-E) were examined in 300 HCC patients after resection. Six Th17 associated cytokines in serum (n = 111) were quantified using enzyme-linked immunosorbent assays. Phenotypic features of IL-17+ CD4+ T cells were determined by flow cytometry analysis. High expression of intratumoral IL-17 and IL1-7RE were significantly associated with poorer survival (p = 0.016 and
ISSN:1756-9966
0392-9078
1756-9966
DOI:10.1186/1756-9966-32-3